How has been the historical performance of Maximus Interna.?

Aug 13 2025 11:12 PM IST
share
Share Via
Maximus Interna. has shown significant growth in net sales and profitability, with net sales increasing from 52.47 Cr in March 2021 to 156.85 Cr in March 2025, and net profit rising from 2.71 Cr to 9.10 Cr in the same period, despite facing cash flow challenges. Total assets grew to 82.10 Cr in March 2024, reflecting overall strong financial performance.
Answer:
The historical performance of Maximus Interna. shows a significant upward trend in net sales and profitability over the years, culminating in the latest figures for March 2025. Breakdown: Maximus Interna. has demonstrated robust growth in net sales, increasing from 52.47 Cr in March 2021 to 156.85 Cr in March 2025. This growth is accompanied by a rise in total operating income, which reached 156.85 Cr in March 2025, up from 30.74 Cr in March 2020. The company's total expenditure has also increased, reflecting higher raw material costs, which rose to 107.39 Cr in March 2025 from 0.00 Cr in March 2021. Operating profit, excluding other income, improved to 13.30 Cr in March 2025, while profit before tax reached 10.34 Cr, indicating a consistent increase in profitability. The net profit for March 2025 was reported at 9.10 Cr, up from 2.71 Cr in March 2020. Additionally, the company's total assets grew to 82.10 Cr in March 2024 from 22.39 Cr in March 2019, while total liabilities also increased to 82.10 Cr in March 2024. Cash flow from operating activities showed a negative trend in March 2024, with a cash outflow of 8.00 Cr, contrasting with positive inflows in previous years. Overall, Maximus Interna. has shown a strong trajectory in sales and profitability, despite facing challenges in cash flow management.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Maximus International Ltd Falls to 52-Week Low of Rs.9.65
Jan 29 2026 10:06 AM IST
share
Share Via
Maximus International Ltd is Rated Sell
Jan 28 2026 10:10 AM IST
share
Share Via
Maximus International Ltd Falls to 52-Week Low of Rs.9.7
Jan 28 2026 10:00 AM IST
share
Share Via
Maximus International Ltd Falls to 52-Week Low of Rs.9.71
Jan 27 2026 11:20 AM IST
share
Share Via
Why is Maximus International Ltd falling/rising?
Jan 14 2026 12:50 AM IST
share
Share Via
Maximus International Ltd is Rated Sell
Jan 05 2026 10:13 AM IST
share
Share Via
Most Read
Saboo Sodium Chloro Ltd is Rated Sell
51 minutes ago
share
Share Via
Jenburkt Pharmaceuticals Ltd. is Rated Sell
51 minutes ago
share
Share Via
iStreet Network Ltd is Rated Sell
51 minutes ago
share
Share Via
Emmbi Industries Ltd is Rated Sell
51 minutes ago
share
Share Via
Cohance Lifesciences Ltd is Rated Sell
51 minutes ago
share
Share Via
Vivo Bio Tech Ltd. is Rated Strong Sell
51 minutes ago
share
Share Via